Recent Security Class Actions
Fennec Pharmaceuticals Inc. Common Stock (NASDAQ: FENC)
Company Name:Fennec Pharmaceuticals Inc. Common Stock
Stock Symbol:NASDAQ: FENC
Class Period Start:12/20/2018
Class Period End (inclusive):08/10/2020
Filing Deadline:11/02/2020
According to the Complaint, Fennec Pharmaceuticals Inc. is a biopharmaceutical company that purportedly focuses on the development of PEDMARK, a sodium thiosulfate anhydrous injection, for the prevention of platinum-induced ototoxicity in pediatric cancer patients.
